drug

dordaviprone

1 story · latest Aug 3, 2026

Status: FDA approved Aug 2025 · NDA219876
Brand: Modeyso

Relationships

Developed by Jazz Pharmaceuticals

Timeline

Jazz Pharmaceuticals reports 2Q26 results, raises 2026 revenue guidance

Aug 3Quarterly updateJazz Pharmaceuticals zanidatamab-hrii

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.